Hermes Vector

Health

WHO issues new guidelines expanding contraceptive options, including mifepristone

The World Health Organization released guidelines adding mifepristone as an emergency contraception option, backing extended use of combined pills and five-year use of implants, and setting out a profile for future male methods.

By Hermes Vector

Also in: Español · Português · Deutsch · हिन्दी

Checked against 1 sourcewho.int
Illustration for: WHO issues new guidelines expanding contraceptive options, including mifepristone

In brief

  • WHO recommends mifepristone at 10-50 mg as an additional emergency contraception option within five days of unprotected sex.
  • Combined oral contraceptive pills can be taken for up to six months extended or one year continuously, WHO says.
  • WHO estimates 164 million women who want to delay or avoid pregnancy are not using contraception.

WHO issues new guidelines expanding contraceptive options, including mifepristone

The World Health Organization on September 23, 2026, published new guidelines on expanding contraceptive options. The guidance adds an emergency contraception option, broadens how existing methods can be used, recommends against two products, and sets out for the first time what future male contraceptive methods should aim to achieve.

WHO estimates that 164 million women who want to delay or avoid pregnancy are not using contraception.

Emergency contraception

WHO now recommends mifepristone as an additional emergency contraception option, taken as soon as possible and within five days of unprotected sex. According to WHO, the evidence shows that mifepristone at doses of 10-50 mg is likely to be as safe and effective as other emergency contraceptive methods.

Pills and implants

WHO recommends that combined oral contraceptive pills can be taken for extended periods of up to six months, or continuously for up to one year, as alternatives to cyclical use.

The guidelines also support the use of contraceptive implants for up to five years. WHO says this could reduce the need for replacement procedures, clinic visits and associated costs.

Methods WHO does not recommend adding

WHO called for more research on ormeloxifene before it is included in family planning programmes, saying current evidence on its safety is limited.

The guideline also recommends against adding quinestrol-containing contraceptive pills to national contraceptive programmes, citing limited evidence and reports of serious adverse events.

A first profile for male contraception

WHO has developed its first Target Product Profile for male contraceptive methods. The document sets out the characteristics that future methods should aim to meet, including safety, effectiveness, acceptability and affordability. It is a guide for developers, not a recommendation of any current product.

"Choice is a gender equality issue," said Pascale Allotey, Director of WHO's Department of Sexual, Reproductive, Maternal, Child and Adolescent Health and Ageing.

Why it matters

WHO guidelines are used by countries to shape national family planning programmes and the methods they offer. The new recommendations add an emergency contraception option, give more flexibility in how pills and implants can be used, and steer programmes away from methods WHO considers insufficiently supported by evidence. Decisions about individual contraceptive use are made with health care providers.


Sources

This article was drafted with AI assistance and checked against the sources above. Company claims are reported as claims. Cover image is AI-generated.

Questions readers ask

When did the World Health Organization publish the new contraceptive guidelines?
The World Health Organization published the new guidelines on September 23, 2026.
What new emergency contraception option does the WHO recommend?
The WHO now recommends mifepristone as an additional emergency contraception option, which should be taken as soon as possible and within five days of unprotected sex.
How long can combined oral contraceptive pills be taken continuously according to the new guidelines?
The guidelines recommend that combined oral contraceptive pills can be taken for extended periods of up to six months, or continuously for up to one year.
Which contraceptive products does the WHO advise against adding to national programs?
The WHO recommends against adding quinestrol-containing contraceptive pills due to limited evidence and reports of serious adverse events, and it calls for more research on ormeloxifene before inclusion.
Why do these WHO guidelines matter for countries?
WHO guidelines are used by countries to shape national family planning programmes and the methods they offer, adding options and flexibility while steering away from insufficiently supported methods.

The day's checked news, by email

One short email a day with the top stories. Free, and you can unsubscribe in one click.

Or follow for the latest news:

How do you feel about this story?

Comments 0

No comments yet. Start the discussion.